ArticleFrontiers in oncology2025

Efficacy and safety of Eribulin-based chemotherapy in HER2 negative advanced breast cancer patients: a real-world study.

Yuting Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.